Levothyroxine Sodium 55-03-8 — China API Manufacturer | EP USP BP R&D to Production

China Manufacturing Landscape for Levothyroxine Sodium

Levothyroxine Sodium (CAS 55-03-8), the sodium salt of the thyroid hormone L-thyroxine (T4), is the most widely prescribed medication for hypothyroidism treatment worldwide, consistently ranking among the top-dispensed pharmaceutical products globally. The enormous and growing global demand for Levothyroxine Sodium API has driven significant manufacturing investment in China, where specialized thyroid hormone production facilities deliver pharmaceutical-grade material to generic drug manufacturers across more than 60 countries. Our production facility is a leading Chinese producer of Levothyroxine Sodium, combining precision chemistry with large-scale production capability.

Given the narrow therapeutic index of thyroid hormone preparations and the critical importance of dose accuracy, Levothyroxine Sodium manufacturing demands exceptional quality control rigor. Our facility has been specifically designed and qualified for thyroid hormone API production, with specialized containment, analytical, and stability monitoring capabilities that meet the exacting requirements of this product class.

Manufacturing Process & Facility Overview

Levothyroxine Sodium production at our facility employs a well-characterized synthesis route involving the selective tetraiodination of the thyronine backbone to produce 3,5,3′,5′-tetraiodothyronine, followed by sodium salt formation under precisely controlled conditions. The iodination process is conducted in dedicated glass-lined reactors with automated temperature and pH control systems, utilizing proprietary process parameters to maximize regioselectivity and minimize formation of diiodo- and triiodo- byproducts.

The production facility features dedicated iodination suites with corrosion-resistant equipment, chromatographic purification systems for isomer removal, controlled crystallization equipment for consistent polymorph production, and pharmaceutical-grade lyophilization for the hydrated sodium salt form. All production areas operate under controlled pharmaceutical conditions with light protection, temperature control, and low-humidity environments to protect the photosensitive and hygroscopic product. Specialized iodine waste treatment and recovery systems are integrated into the facility design.

Quality Standards & Multi-Pharmacopeial Compliance

Our Levothyroxine Sodium API is manufactured and tested in strict compliance with European Pharmacopoeia (EP), United States Pharmacopeia (USP), and British Pharmacopoeia (BP) monograph specifications. The complete quality control program includes assay by validated HPLC method (purity ≥98.0%), identification by IR spectroscopy and specific HPLC retention time, related substances analysis with particular focus on liothyronine (T3) and diiodothyronine content, specific optical rotation measurement, water content by Karl Fischer titration, iodide content, and heavy metals determination by ICP-MS.

Enhanced quality measures specific to narrow therapeutic index drugs include tightened assay limits, extended content uniformity studies to support customer dosage form development, and complete forced degradation studies demonstrating the stability-indicating nature of analytical methods. Our QC laboratory maintains specialized iodothyronine HPLC methods with demonstrated ability to resolve all pharmacopeially specified impurities.

Regulatory Documentation & Export Support

We provide extensive regulatory documentation supporting customer registrations for Levothyroxine Sodium formulations in regulated and emerging markets. Our documentation package includes US FDA Drug Master File (DMF), EDQM Certificate of Suitability (CEP), WHO Prequalification supporting documentation, ICH-compliant stability data, complete impurity qualification packages, process validation reports, and detailed analytical method validation documentation. Batch-specific Certificates of Analysis with enhanced testing data, MSDS/SDS, and Certificates of Origin are provided with every shipment.

Our regulatory affairs team has extensive experience with thyroid hormone API registrations and provides responsive support for customer filing activities, including handling of bioequivalence study API supply coordination and responses to regulatory authority questions specific to narrow therapeutic index products.

Packaging & Global Logistics

Levothyroxine Sodium is packaged in amber glass bottles with PTFE-lined closures, sealed under nitrogen atmosphere with desiccant, and placed in secondary light-protective containers. Standard packaging units include 100 g, 500 g, 1 kg, and 5 kg configurations. All packaging operations are conducted under reduced lighting and controlled humidity conditions to maintain product stability. Each package carries complete batch traceability and GHS-compliant labeling.

Temperature-controlled shipping (15-25°C) is provided as standard for all Levothyroxine Sodium shipments to maintain product integrity during transit. We offer FOB, CIF, and DDP Incoterms with routing through Shanghai. Air freight is the preferred mode with delivery within 3-5 business days globally, while temperature-controlled ocean freight is available for larger shipments with transit times of 20-30 days.

Competitive Pricing & Supply Reliability

Our specialized thyroid hormone manufacturing infrastructure and optimized synthesis processes enable competitive competitive pricing for Levothyroxine Sodium API. We offer flexible pricing programs with volume-based discounts, annual contract pricing with stability guarantees, and development-to-commercial pricing transitions. Our pricing structure supports the cost-competitive positioning needed for generic thyroid medications in price-sensitive markets.

Supply reliability for this essential medication is a top priority, and we maintain strategic finished goods and intermediate inventory to ensure continuous availability. Our thyroid hormone production line operates with demonstrated on-time delivery performance exceeding 97%, supported by dedicated account management and proactive supply chain communication.

Levothyroxine Sodium Technical Specifications